HemoShear retweeted
.@PoliticoPro 👏for covering the shortage of live-saving specialty formulas. Life-saving, yet insurance companies deny coverage & risk patients' lives. Congress must pass #MedicalNutritionEquityAct 👏@SenBobCasey @SenJoniErnst @RepMcGovern @HerreraBeutler for your leadership.
HemoShear retweeted
Just had an opinion piece on rare disease go up on The Hill.
thehill.com/opinion/healthca…
HemoShear retweeted
HemoShear is growing! Paul has joined us as VP of Organizational Development and HR, and Wanda is Director of Talent Acquisition. We are #hiring for several positions in scientific research, clinical operations and administration. For job postings, visit hemoshear.com/careers
HemoShear retweeted
We just announced that the FDA has authorized the Moderna COVID-19 Vaccine in the U.S. for emergency use to prevent COVID-19 in individuals 18 and over. The Moderna COVID-19 Vaccine has not been approved or licensed by the FDA. buff.ly/34oHMjW
HemoShear retweeted
As a company, we condemn racism in all its abhorrent forms, including anti-Black racism and stand in solidarity with our Black colleagues & Black communities around the country. At Horizon, we believe that when people from different backgrounds stand together, we rise together.
HemoShear retweeted
A webinar on the potential impact of COVID-19 on people with Inherited Metabolic Disease. #coronavirus #COVID19 #imd #inbornerrors youtu.be/I9jyO-bOQU4
HemoShear retweeted
Thanks for today’s #NIHchat. I want to reach out to our rare disease families & partners and invite you to celebrate @rarediseaseday with us Feb. 28 @ChildrensNatl .
HemoShear retweeted
Proud of @HemoShear Ryan Feaver, Banu Cole and #Nash Team for 4th @AASLDtweets Presidential Award. Hard work and focus, great work!
HemoShear retweeted
.@HemoShear is only company that recreates rare diseases in the lab to create new treatments. #AmericasFoundingCity
HemoShear retweeted
Drug developers fund patient registries to collect data on rare diseases statnews.com/2015/12/16/1747… via statnews
HemoShear retweeted
Replying to @HemoShear
@HemoShear Therapeutics names former Human Genome Sciences #CEO H. Thomas Watkins to its #boardofdirectors. ow.ly/V1CI4
HemoShear retweeted
Marshall Summar and @Brian_Wamhoff speaking about how to research extremely rare genetic conditions in children. (@HemoShear) #TEDxCville
HemoShear retweeted
Dr. Summar sits down w/ @HemoShear CEO, James C. Power, to discuss technological changes in the rare disease field. ow.ly/HRvjp
HemoShear retweeted
PFE and @HemoShear collaboration to help identify and predict drug-induced #vascular injury on.pfizer.com/1z0VFjK
HemoShear retweeted
Dr. @Brian_Wamhoff co-founder of @HemoShear tells us how their technology enables new ways of studying human disease tinyurl.com/kdww5ck
HemoShear retweeted
Jim Powers of @HemoShear : his 40 young pharmaceutical scientists must grow 2 200 -needs Va 2 grow science community
HemoShear retweeted
.@HemoShear Brian Wamhoff @childrenshealth Marshall Summar:"mice are not people. things we try to treat can't be treated in animal models."
HemoShear retweeted
Replying to @HemoShear
HemoShear retweeted
HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Disc... yhoo.it/1xP6Fyi

























